| Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88444536 | FILING DATE | 05/23/2019 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | TENG, SIMON |
L.O. ASSIGNED | 105 |
PUB INFORMATION |
|||
| RUN DATE | 03/07/2020 | ||
| PUB DATE | N/A | ||
| STATUS | 680-APPROVED FOR PUBLICATION | ||
| STATUS DATE | 03/06/2020 | ||
| LITERAL MARK ELEMENT | CVCM | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | NO | 1 (b) | NO | 1 (b) | NO |
| 44D | YES | 44D | NO | 44D | NO |
| 44E | NO | 44E | YES | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | CVCM |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | CureVac AG |
| ADDRESS | Paul-Ehrlich-Str. 15 Tübingen, 72076 |
| ENTITY | 25 |
| CITIZENSHIP | Germany |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 001 |
| DESCRIPTION TEXT | Chemical reagents and biomolecules, in particular biological macromolecules in the nature of nucleic acid for industrial or scientific purposes; Reagents for research purposes |
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements, namely, dietary food supplements |
| INTERNATIONAL CLASS | 042 |
| DESCRIPTION TEXT | Scientific and technological services, namely, technical biology consulting and scientific research services, in particular for identifying and characterizing biological macromolecules; pre-clinical and clinical testing of macromolecules |
| INTERNATIONAL CLASS | 044 |
| DESCRIPTION TEXT | Medical and veterinary services, in particular for therapeutic and preventative treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 001 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 042 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 044 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
FOREIGN INFORMATION |
|
| PRIORITY CLAIMED | SEC. 44(D) ON European Union |
| APPLICATION NO. | 018070328 |
| APPLICATION FILING DATE | 05/22/2019 |
| FOREIGN REG NO. | 018070328 |
| FOREIGN REG DATE | 10/29/2019 |
| FOREIGN RNWL NUM | N/A |
| DATE OF FOREIGN RNWL | N/A |
| FOREIGN EXPIRATION | 05/22/2029 |
| FOREIGN RNWL EXPIRATION | N/A |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 03/06/2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | 017 |
| 03/05/2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 016 |
| 03/05/2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 015 |
| 03/02/2020 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 014 |
| 02/22/2020 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 013 |
| 02/22/2020 | GNSL | S | LETTER OF SUSPENSION E-MAILED | 012 |
| 02/22/2020 | CNSL | R | SUSPENSION LETTER WRITTEN | 011 |
| 02/10/2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 010 |
| 02/10/2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 009 |
| 02/10/2020 | ALIE | A | ASSIGNED TO LIE | 008 |
| 02/03/2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
| 08/13/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
| 08/13/2019 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
| 08/13/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
| 08/10/2019 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 06/08/2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 05/27/2019 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Jennifer Fraser |
| CORRESPONDENCE ADDRESS | Jennifer Fraser DYKEMA GOSSETT PLLC 1301 K ST., NW SUITE 1100 WEST WASHINGTON, DC 20005 |
| DOMESTIC REPRESENTATIVE | Jennifer Fraser |